Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (4130)	7/9/1998 7:01:00 PM
From: Nick	Read Replies (2) \| Respond to of 9523

AFTER THE BELL-Pfizer drops slightly on news NEW YORK, July 9 (Reuters) - Shares of Pfizer Inc. dropped slightly in after hours trading Thursday despite beating analysts expectations when it reported its second quarter earnings of $0.47 per share, traders said. The drug company was at 115 in after-hours trading, according to Instinet Inc., down slightly from the close at 115-5/16. First Call estimates put expected earnings per share at $0.45 for the second quarter. Drug maker Vivus Inc., a company whose own impotency treatment, Muse, was sent reeling by the success of Pfizer's Viagra, was trading just below the close after reporting a loss of $0.76 per share. That loss inred with 1,797,299 Wednesday, and session two volume was 6,191,498 compared with 58,320 Wednesday.